Medscape InDiscussion: Dyslipidemia

About Medscape InDiscussion: Dyslipidemia

Join Dr Laurence Sperling for "Medscape InDiscussion: Dyslipidemia," a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/958283). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Publisher

Medscape

Category

health & fitness · science

Language

en

Explicit

No

First episode

21 Oct 2021

Latest episode

15 Feb 2022

Latest episodes

6 episodes in the feed.

1. 

   15 Feb 2022

   Recent Clinical Advances in Reducing Risk for Dyslipidemia

   In this episode, host Dr. Laurence Sperling speaks with Drs Erin Michos and Peter Toth about optimal use of newer dyslipidemia therapies. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/958749). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals. Resources Cholesterol Treatment Trial: Efficacy and Safety of More Intensive Lowering of LDL Cholesterol: A Meta-analysis Of Data From 170,000 Participants in 26 Randomised Trials https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988224/ IMPROVE-IT: Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes https://www.nejm.org/doi/full/10.1056/nejmoa1410489 ODYSSEY: Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome https://www.nejm.org/doi/full/10.1056/nejmoa1801174 FOURIER: Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk -- FOURIER https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2017/03/16/00/46/FOURIER Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.037184 ORION: Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol https://pubmed.ncbi.nlm.nih.gov/32187462/ CLEAR Wisdom: Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865290/ Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121276/ CLEAR Outcomes: Rationale and Design of the CLEAR-Outcomes Trial: Evaluating the Effect of Bempedoic Acid on Cardiovascular Events in Patients With Statin Intolerance https://pubmed.ncbi.nlm.nih.gov/33470195/ CLEAR Wisdom: Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination in Patients With Hypercholesterolemia and High CVD Risk Treated With Maximally Tolerated Statin Therapy https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865290/ Bempedoic Acid and Ezetimibe -- Better Together https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203625/ REDUCE-IT: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia https://www.nejm.org/doi/full/10.1056/nejmoa1812792 STRENGTH: Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia -- STRENGTH https://www.acc.org/latest-in-cardiology/clinical-trials/2020/11/11/21/29/strength JELIS: Effects of Eicosapentaenoic Acid on Major Coronary Events in Hypercholesterolaemic Patients (JELIS): A Randomised Open-Label, Blinded Endpoint Analysis https://pubmed.ncbi.nlm.nih.gov/17398308/ PROMINENT: Rationale and Design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) Study https://pubmed.ncbi.nlm.nih.gov/30342298/ How Low Is Safe? The Frontier of Very Low (SPARCL: High-Dose Atorvastatin After Stroke or Transient Ischemic Attack https://www.nejm.org/doi/full/10.1056/nejmoa061894 EBBINGHAUS: Cognitive Function in a Randomized Trial of Evolocumab https://www.nejm.org/doi/full/10.1056/nejmoa1701131 PROSPER: Pravastatin in Elderly Individuals at Risk of Vascular Disease (PROSPER): A Randomized Controlled Trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)11600-X/fulltext Achievement of Very Low Low-Density Lipoprotein Cholesterol Levels https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.119.044275

2. 

   13 Jan 2022

   A Natural Winner: Plant-Based Diets and Statins vs Dyslipidemia Risk

   In this episode, Dr Laurence Sperling talks with Dr Kim Williams about preventive cardiology nutrition intervention as a key co-therapy for tackling dyslipidemia. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/958748). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals. Resources Exercise and CVD Mortality Associations of specific types of sports and exercise with all-cause and cardiovascular-disease mortality: a cohort study of 80,306 British adults https://bjsm.bmj.com/content/51/10/812#T3 Diet and Dietary Patterns The reasons for geographic and racial differences in stroke study: objectives and design https://pubmed.ncbi.nlm.nih.gov/15990444/ Heart disease and stroke https://www.cdc.gov/chronicdisease/resources/publications/factsheets/heart-disease-stroke.htm Effects of ketogenic diets on cardiovascular risk factors: evidence from animal and human studies https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452247/ Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000510 Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study https://www.thelancet.com/article/S0140-6736(17)32252-3/fulltext Intensive lifestyle changes for reversal of coronary heart disease https://pubmed.ncbi.nlm.nih.gov/9863851/ Dietary adherence and acceptability of five different diets, including vegan and vegetarian diets, for weight loss: the New DIETs study https://www.sciencedirect.com/science/article/abs/pii/S147101531500080X Guidelines and Population Studies 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk https://academic.oup.com/eurheartj/article/41/1/111/5556353 TMAO Trimethylamine-N-oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease https://www.nature.com/articles/s41598-019-52082-z Gut microbes impact stroke severity via the trimethylamine N-oxide pathway https://pubmed.ncbi.nlm.nih.gov/34139173/ Statin Adverse Effects Effects of coenzyme Q10 on statin‐induced myopathy: an updated meta‐analysis of randomized controlled trials https://www.ahajournals.org/doi/10.1161/JAHA.118.009835 N-of-1 trial of a statin, placebo, or no treatment to assess side effects https://www.nejm.org/doi/full/10.1056/NEJMc2031173

3. 

   15 Dec 2021

   Top 10 Take-home Messages From the 2018 ACC/AHA Cholesterol Guidelines

   Drs Laurence Sperling and Neil Stone put key messages from the 2018 cholesterol guidelines into a clear clinical context. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/958747). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals. Resources 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625 ASCVD Risk Estimator Plus https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/ 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia https://www.jacc.org/doi/10.1016/j.jacc.2021.06.011 What Do US Physicians and Patients Think About Lipid‐Lowering Therapy and Goals of Treatment? Results From the GOULD Registry https://www.ahajournals.org/doi/10.1161/JAHA.120.020893 Statin Treatment and Muscle Symptoms: Series of Randomised, Placebo Controlled n-of-1 Trials https://www.bmj.com/content/372/bmj.n135

4. 

   15 Nov 2021

   How to Improve Dyslipidemia Care in Underresourced Populations

   Drs Larry Sperling and Karol Watson discuss health equity and social determinants of health for populations with dyslipidemia. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/958746). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625 Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease https://www.ahajournals.org/doi/10.1161/CIR.0000000000000638 New AMA Policies Recognize Race as a Social, Not Biological, Construct https://www.ama-assn.org/press-center/press-releases/new-ama-policies-recognize-race-social-not-biological-construct Race/Ethnicity, Neighborhood Socioeconomic Status and Cardio-metabolic Risk https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397689/ Disparities in Hypertension and Cardiovascular Disease in Blacks: The Critical Role of Medication Adherence https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638710/ Racial and Ethnic Disparities in Heart and Cerebrovascular Disease Deaths During the COVID-19 Pandemic in the United States https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191372/

5. 

   21 Oct 2021

   Pandemic Flips Script on Patient-Partnered Dyslipidemia Care

   In this episode, host Dr Laurence Sperling and guests talk about how COVID affected patient-partnered dyslipidemia care, causing clinical teams to innovate. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/958311). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals. Resources Patel P, Dhindsa D, Eapen DJ, et al. Optimizing the potential for telehealth in cardiovascular care (in the era of COVID-19): time will tell. Am J Med. 2021;134:945-951. doi:10.1016/j.amjmed.2021.03.007 American Medical Association. Telemedicine and team-based care: improve patient care and team engagement by using team-based care in telemedicine. https://edhub.ama-assn.org/steps-forward/module/2781279 Bhaskar S, Bradley S, Chattu VK, et al. Telemedicine as the new outpatient clinic gone digital: position paper from the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (part 2). Front Public Health. 2020;8:410. doi:10.3389/fpubh.2020.00410 Arevian AC, Springgate B, Jones F, et al. The Community and Patient Partnered Research Network (CPPRN): application of patient-centered outcomes research to promote behavioral health equity. Ethn Dis. 2018;28(Suppl 2):295-302. doi: 10.18865/ed.28.S2.295. Stewart MP, Fink R, Kosirog E, Saseen JJ. Bridging health disparities: a national survey of ambulatory care pharmacists in underserved areas. Pharm Pract (Granada). 2021;19:2359. doi:10.18549/PharmPract.2021.2.2359 Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Circulation. 2019 Jun 18;139(25):e1182-e1186]. Circulation. 2019;139(25):e1082-e1143. Golden RL. William Osler at 150: An Overview of a Life. JAMA. 1999;282:2252–2258. doi:10.1001/jama.282.23.2252

6. 

   21 Oct 2021

   Familial Hypercholesterolemia -- Hiding in Plain Sight

   In this episode, host Dr Laurence Sperling speaks with Katherine Wilemon, founder of the FH Foundation. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/958283). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals. Resources The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association https://www.ahajournals.org/doi/10.1161/CIR.0000000000000297?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Familial Hypercholesterolemia Foundation https://thefhfoundation.org/ Cascade Registry https://thefhfoundation.org/fh-research/registry Finding missed cases of familial hypercholesterolemia in health systems using machine learning https://www.nature.com/articles/s41746-019-0101-5 Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2020/08/27/13/28/genetic-testing-in-dyslipidemia Genetic Testing for Managing Dyslipidemia https://www.acc.org/Latest-in-Cardiology/Articles/2020/11/13/20/26/Genetic-Testing-for-Managing-Dyslipidemia

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

4 ratings

Contact Medscape InDiscussion: Dyslipidemia

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.